{
    "eid": "2-s2.0-85051792172",
    "title": "Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non\u2013Small Cell Lung Cancer",
    "cover-date": "2018-10-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pulmonary and Respiratory Medicine",
            "@code": "2740",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "ALK-positive advanced non\u2013small cell lung cancer",
        "chemotherapy",
        "crizotinib",
        "phase III"
    ],
    "authors": [
        "Yi Long Wu",
        "Shun Lu",
        "You Lu",
        "Jianying Zhou",
        "Yuan kai Shi",
        "Virote Sriuranpong",
        "James C.M. Ho",
        "Choo Khoon Ong",
        "Chun Ming Tsai",
        "Chin Hee Chung",
        "Keith D. Wilner",
        "Yiyun Tang",
        "Elizabeth T. Masters",
        "Paulina Selaru",
        "Tony S. Mok"
    ],
    "citedby-count": 134,
    "ref-count": 17,
    "ref-list": [
        "Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer",
        "Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer",
        "Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression",
        "Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases",
        "Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma",
        "Preclinical rationale for use of the clinically available multitargeted tyrosine kinase inhibitor crizotinib in ROS1-translocated lung cancer",
        "First-line crizotinib versus chemotherapy in ALK-positive lung cancer",
        "Crizotinib versus chemotherapy in advanced ALK-positive lung cancer",
        "New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)",
        "The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology",
        "Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer",
        "The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life",
        "EuroQol\u2014a new facility for the measurement of health-related quality of life",
        "First-line crizotinib vs pemetrexed + cisplatin/carboplatin in Asian patients with advanced ALK+ NSCLC in PROFILE 1014",
        "Clinical implications of the pharmacokinetics of crizotinib in populations of patients with non-small cell lung cancer",
        "First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study"
    ],
    "affiliation": [
        {
            "affiliation-city": null,
            "@id": "60103837",
            "affilname": "Hospital Pulau Pinang",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60103837",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Chengdu",
            "@id": "60073509",
            "affilname": "West China School of Medicine/West China Hospital of Sichuan University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073509",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Beijing",
            "@id": "60073456",
            "affilname": "Cancer Institute &amp; Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073456",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Guangzhou",
            "@id": "60069718",
            "affilname": "Guangdong Provincial People\u2019s Hospital of Southern Medical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60069718",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Hangzhou",
            "@id": "60029310",
            "affilname": "Zhejiang University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029310",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Shanghai",
            "@id": "60025084",
            "affilname": "Shanghai Jiao Tong University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025084",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Taipei",
            "@id": "60013314",
            "affilname": "Veterans General Hospital-Taipei",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013314",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "New York",
            "@id": "60006989",
            "affilname": "Pfizer Inc.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006989",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Hong Kong",
            "@id": "60006541",
            "affilname": "The University of Hong Kong",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006541",
            "affiliation-country": "Hong Kong"
        },
        {
            "affiliation-city": "Hong Kong",
            "@id": "60002798",
            "affilname": "Chinese University of Hong Kong",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002798",
            "affiliation-country": "Hong Kong"
        },
        {
            "affiliation-city": "New York",
            "@id": "117725381",
            "affilname": "Pfizer Oncology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/117725381",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "Pfizer Inc."
    ]
}